BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 34328682)

  • 1. The epileptogenic zone in children with tuberous sclerosis complex is characterized by prominent features of focal cortical dysplasia.
    Hulshof HM; Benova B; Krsek P; Kyncl M; Lequin MH; Belohlavkova A; Jezdik P; Braun KPJ; Jansen FE
    Epilepsia Open; 2021 Dec; 6(4):663-671. PubMed ID: 34328682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinctive MRI features of the epileptogenic zone in children with tuberous sclerosis.
    Jahodova A; Krsek P; Kyncl M; Jezdik P; Kudr M; Komarek V; Jayakar P; Miller I; Resnick T; Duchowny M
    Eur J Radiol; 2014 Apr; 83(4):703-9. PubMed ID: 24447419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited utility of structural MRI to identify the epileptogenic zone in young children with tuberous sclerosis.
    Nijman M; Yang E; Jaimes C; Prohl AK; Sahin M; Krueger DA; Wu JY; Northrup H; Stone SSD; Madsen JR; Fallah A; Blount JP; Weiner HL; Grayson L; Bebin EM; Porter BE; Warfield SK; Prabhu SP; Peters JM;
    J Neuroimaging; 2022 Sep; 32(5):991-1000. PubMed ID: 35729081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gray-matter-specific MR imaging improves the detection of epileptogenic zones in focal cortical dysplasia: A new sequence called fluid and white matter suppression (FLAWS).
    Chen X; Qian T; Kober T; Zhang G; Ren Z; Yu T; Piao Y; Chen N; Li K
    Neuroimage Clin; 2018; 20():388-397. PubMed ID: 30128277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia.
    Talos DM; Sun H; Kosaras B; Joseph A; Folkerth RD; Poduri A; Madsen JR; Black PM; Jensen FE
    Ann Neurol; 2012 Apr; 71(4):539-51. PubMed ID: 22447678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of complement components in tuberous sclerosis complex and focal cortical dysplasia type 2B brain lesions.
    Gruber VE; Luinenburg MJ; Colleselli K; Endmayr V; Anink JJ; Zimmer TS; Jansen F; Gosselaar P; Coras R; Scholl T; Blumcke I; Pimentel J; Hainfellner JA; Höftberger R; Rössler K; Feucht M; van Scheppingen J; Aronica E; Mühlebner A
    Epilepsia; 2022 Feb; 63(2):364-374. PubMed ID: 34904712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolated cortical tuber in an infant with genetically confirmed tuberous sclerosis complex 1 presenting with symptomatic West syndrome.
    Miyata H; Fushimi S; Ota Y; Vinters HV; Adachi K; Nanba E; Akiyama T
    Neuropathology; 2021 Feb; 41(1):58-64. PubMed ID: 33181865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Case of a Solitary Cortical Tuber with No Other Manifestations of Tuberous Sclerosis Complex Mimicking Focal Cortical Dysplasia Type II with Calcification.
    Hosomoto K; Sasaki T; Kawai K; Okazaki Y; Hyodo Y; Shibata T; Sasada S; Yasuhara T; Kobayashi K; Yanai H; Date I
    Acta Med Okayama; 2022 Jun; 76(3):323-328. PubMed ID: 35790363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mTOR Hyperactivity Levels Influence the Severity of Epilepsy and Associated Neuropathology in an Experimental Model of Tuberous Sclerosis Complex and Focal Cortical Dysplasia.
    Nguyen LH; Mahadeo T; Bordey A
    J Neurosci; 2019 Apr; 39(14):2762-2773. PubMed ID: 30700531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A distinct microRNA expression profile is associated with α[
    Bagla S; Cukovic D; Asano E; Sood S; Luat A; Chugani HT; Chugani DC; Dombkowski AA
    Neurobiol Dis; 2018 Jan; 109(Pt A):76-87. PubMed ID: 28993242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epileptogenicity in tuberous sclerosis complex: A stereoelectroencephalographic study.
    Neal A; Ostrowsky-Coste K; Jung J; Lagarde S; Maillard L; Kahane P; Touraine R; Catenoix H; Montavont A; Isnard J; Arzimanoglou A; Bartolomei F; Guenot M; Rheims S
    Epilepsia; 2020 Jan; 61(1):81-95. PubMed ID: 31860139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doublecortin-like (DCL) expression in focal cortical dysplasia and cortical tubers.
    Boer K; Lucassen PJ; Spliet WG; Vreugdenhil E; van Rijen PC; Troost D; Jansen FE; Aronica E
    Epilepsia; 2009 Dec; 50(12):2629-37. PubMed ID: 19583781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmantle sign in focal cortical dysplasia: a unique radiological entity with excellent prognosis for seizure control.
    Wang DD; Deans AE; Barkovich AJ; Tihan T; Barbaro NM; Garcia PA; Chang EF
    J Neurosurg; 2013 Feb; 118(2):337-44. PubMed ID: 23216463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Early MRI Characteristics With Subsequent Epilepsy and Neurodevelopmental Outcomes in Children With Tuberous Sclerosis Complex.
    Hulshof HM; Kuijf HJ; Kotulska K; Curatolo P; Weschke B; Riney K; Krsek P; Feucht M; Nabbout R; Lagae L; Jansen A; Otte WM; Lequin MH; Sijko K; Benvenuto A; Hertzberg C; Benova B; Scholl T; De Ridder J; Aronica EMA; Kwiatkowski DJ; Jozwiak S; Jurkiewicz E; Braun K; Jansen FE;
    Neurology; 2022 Mar; 98(12):e1216-e1225. PubMed ID: 35101906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Histopathological Patterns in Cortical Tubers of Epilepsy Surgery Patients with Tuberous Sclerosis Complex.
    Mühlebner A; van Scheppingen J; Hulshof HM; Scholl T; Iyer AM; Anink JJ; van den Ouweland AM; Nellist MD; Jansen FE; Spliet WG; Krsek P; Benova B; Zamecnik J; Crino PB; Prayer D; Czech T; Wöhrer A; Rahimi J; Höftberger R; Hainfellner JA; Feucht M; Aronica E
    PLoS One; 2016; 11(6):e0157396. PubMed ID: 27295297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of leukocyte immunoglobulin-like receptor B2 signaling pathway in cortical lesions of pediatric patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
    Yue J; Zhang C; Shi X; Wei Y; Liu L; Liu S; Yang H
    Brain Dev; 2019 Nov; 41(10):829-838. PubMed ID: 31495513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in vascular density in resected tissue of 97 patients with mild malformation of cortical development, focal cortical dysplasia or TSC-related cortical tubers.
    Veersema TJ; de Neef A; van Scheppingen J; Ferrier CH; van Eijsden P; Gosselaar PH; van Rijen PC; Spliet WGM; Braun KPJ; Mühlebner A; Aronica E
    Int J Dev Neurosci; 2019 Dec; 79():96-104. PubMed ID: 31770571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of MRI features and surgical outcome among the subtypes of focal cortical dysplasia.
    Kim DW; Kim S; Park SH; Chung CK; Lee SK
    Seizure; 2012 Dec; 21(10):789-94. PubMed ID: 23040369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive model for epileptogenic tubers from all tubers in patients with tuberous sclerosis complex based on
    Wang Z; Li Y; He Z; Li S; Huang K; Shi X; Sun X; Ruan R; Cui C; Wang R; Wang L; Lv S; Zhang C; Liu Z; Yang H; Yang X; Liu S
    BMC Med; 2023 Dec; 21(1):500. PubMed ID: 38110931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphometric MRI analysis enhances visualization of cortical tubers in tuberous sclerosis.
    House PM; Holst B; Lindenau M; Voges B; Kohl B; Martens T; Lanz M; Stodieck S; Huppertz HJ
    Epilepsy Res; 2015 Nov; 117():29-34. PubMed ID: 26370915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.